Antiandrogens in hormonal contraception limit muscle strength gain in strength training: comparison study

Croat Med J. 2003 Feb;44(1):65-8.

Abstract

Aim: To determine antiandrogen effects on muscle strength gain and fat-free mass increase during exercise in women using hormonal contraception with antiandrogen content.

Methods: The study included 50 women (age range, 18-30 years; mean-/+SD, 26-/+3) using hormonal contraception for at least 12 months before the beginning of the study. They were divided into two groups: "antiandrogen" group (n=26) and "estrogen-progestogen" group (n=24) groups. The subjects participated in strength training sessions 3 times a week during 16 weeks. Initially, there were no differences between the groups in fat-free mass, muscle strength, or maximum oxygen uptake. The parameters were measured before, during, and after the training period.

Results: After the training period, the mean increase of fat-free mass was significantly greater in the estrogen-progestogen group (p<0.001). The mean gain in the muscle strength (in Newtons) was also more evident in estrogen-progestogen group (1289.0-/+17.1 N vs 101.9-/+18.5 N; p<0.001). There were no differences in the maximum oxygen consumption (VO(2)max).

Conclusion: Antiandrogens had a negative effect on muscle strength, minimizing the effects of strength training in women. Hormonal contraception containing antiandrogens should be avoided in young exercising women.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / pharmacology*
  • Contraceptives, Oral, Hormonal / pharmacology*
  • Cyproterone Acetate / administration & dosage
  • Cyproterone Acetate / pharmacology*
  • Exercise*
  • Female
  • Humans
  • Isometric Contraction / drug effects*
  • Muscle, Skeletal / physiology*
  • Physical Fitness

Substances

  • Androgen Antagonists
  • Contraceptives, Oral, Hormonal
  • Cyproterone Acetate